HIGHLIGHTS
- who: Oskar Estradu00e9 et al. from the Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, University of Florida, Biocruces Health Research Institute, Barakaldo, Spain have published the article: Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability, in the Journal: Antibiotics 2022, 641 of 11/05/2022
- what: The aim of this study was to review the published literature about interindividual in pharmacological processes that can be responsible for the clinical response after empiric dose for the most commonly prescribed urological FQs: ciprofloxacin levofloxacin and moxifloxacin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.